In what St. Jude hopes will be a happy marriage, it will acquire the heart assist device company in an all cash transaction that represents a significant premium
Cardio
First U.S. Patients for Biotronik’s Newly Approved Itrevia HF-T QP CRT-D Device
Device incorporates latest defibrillator technology, closed loop stimulation and compatibility with a quadripolar lead
Edwards Lifesciences to Acquire CardiAQ™
Edwards Lifesciences Corporation is to acquire privately held CardiAQ™ Valve Technologies, Inc., developer of a transcatheter mitral valve replacement system.
St. Jude’s CardioMEMS HF System Featured at Premier, Inc.’s 2015 ‘Innovation Celebration’ Breakthroughs Conference
CardioMEMS allows patient heart data to be transmitted to health providers who can then manage medication to reduce hospitalization risk
New U.S. Clinical Support for Sorin’s Solo Smart Pericardial Aortic Valve
Solo Smart offers the superior hemodynamics of a stentless valve combined with a stented valve’s ease of implantation
CardiAQ™ Sees First Human Implant of its Transcatheter Mitral Heart Valve
Second-generation bioprosthetic mitral heart valve successfully implanted in severe mitral regurgitation patient
Direct Flow Medical® Names Co-principal Investigator for U.S. Pivotal Study
Transcatheter valve implantation using the novel Direct Flow “inflatable” valve has moved a step closer as the company appoints study leader
Improved Valve Function at Six Months Using Mitralign Percutaneous Annuloplasty System
Mitralign’s Annuloplasty system is designed to treat Mitral and functional Tricuspid regurgitation. New study data suggests it offers hope for a challenging patient population
Registry Data Supports Direct Flow’s Promise
Hot on the heels of its recent study, new registry data from DISCOVER trial provides evidence that reinforces earlier favourable outcomes
Polymer and Carrier-Free Stent Demonstrates Early Healing in OCT Study
New study points to rapid early healing and sustained performance from novel BioFreedom stent
CE Mark for Abbott’s New Absorb GT1™ Stent System
New generation of Abbott’s absorbable stent line features improved access and deliverability
Two Year Data Leaves Direct Flow Medical® Pumped Up About TAVI Outcomes
Uniquely implanted transcatheter valve demonstrates 80 percent survival at two years in severe aortic valve stenosis patients
CE Mark for Arterial Remodeling Technologies’ Pure Bioresorbable Scaffold
Arterial Remodeling Technologies has gained CE Mark approval for its next generation drug free, pure bioresorbable scaffold used to treat coronary artery disease
Good Press for St. Jude Medical’s Quadripolar Technology at HRS 2015
Presentations at this year’s HRS event point to improved clinical outcomes, increased survival and better cost utilization with the SJM™ Quadra CRT system
CE Mark of Perivascular Alcohol Denervation System for Hypertension
CE Mark of the Ablative Solutions Peregrine System™ Infusion Catheter signals continued interest in renal denervation therapy
EU Nod for St. Jude’s ICD MRI-Compatibility Claim
MRI-conditionality is rapidly becoming industry standard, at least in St. Jude’s range, as more ICD products are approved to make this claim in Europe